Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Le informazioni sui progetti di Orizzonte 2020 e ora anche le relative sintesi delle relazioni sono disponibili su CORDIS. Tutti i progetti H2020 possono essere scaricati dal Portale Open Data dell'UE .

My refinements


Download results of this page


Perfeziona per:

Tipo di contenuto

Progetto (688)
Risultato in breve (12)
Sintesi della relazione (333)

Paese

Albania (2)
Argentina (2)
Australia (16)
Austria (80)
Bangladesh (1)
Belgio (154)
Benin (1)
Brasile (4)
Bulgaria (10)
Burkina Faso (1)
Cambogia (1)
Canada (16)
Cina (2)
Cipro (12)
Colombia (2)
Corea del Sud (6)
Costa d’Avorio (1)
Croazia (14)
Cuba (2)
Danimarca (113)
Ecuador (1)
Estonia (20)
Ex Repubblica iugoslava di Macedonia (3)
Finlandia (92)
Francia (234)
Gabon (2)
Germania (314)
Ghana (1)
Giamaica (1)
Giappone (1)
Grecia (77)
India (1)
Irlanda (64)
Islanda (11)
Israele (53)
Italia (254)
Kirghizistan (1)
Kosovo (2)
Lettonia (12)
Lituania (2)
Lussemburgo (17)
Malawi (2)
Malta (2)
Messico (2)
Mozambico (2)
Nepal (2)
Norvegia (49)
Nuova Caledonia (1)
Paesi Bassi (262)
Pakistan (2)
Polinesia francese (1)
Polonia (46)
Portogallo (62)
Regno Unito (350)
Repubblica ceca (31)
Romania (22)
Senegal (4)
Serbia (11)
Slovacchia (11)
Slovenia (30)
Spagna (272)
Sri Lanka (1)
Stati Uniti (54)
Sud Africa (5)
Svezia (145)
Svizzera (95)
Tagikistan (1)
Taiwan (4)
Tanzania (3)
Turchia (15)
Ucraina (1)
Uganda (5)
Ungheria (31)
Vietnam (1)
Zambia (1)

Advanced search

Cerca progetti e risultati

Results 1 - 10 of 1033
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Periodic Reporting for period 1 - ATx201 (A novel class of antibiotics for treatment of infected atopic dermatitis: an innovative solution for a significant unmet medical need)
AntibioTx`s innovation project to cure infected AD will bring several societal benefits within the European boundaries and beyond, mostly related to the Health dimension. As well as being a value in itself, health is a precondition for economic prosperity and efficient...
Programme: H2020-EU.3.1.
Record Number: 198211
Last updated on: 2017-05-17
Periodic Reporting for period 1 - HbMP-700 (The World's First Safe and Efficacious Human Blood Substitute: HbMP-700, a Haemoglobin based oxygen carrier, based on bovine blood.)
About 100 Mio. blood transfusions are performed worldwide p.a. Today, no substitute for human blood as an oxygen carrier exists. CC-Ery develops HbMP-700, the first safe and effective human blood substitute for the use in Red Blood Cell (RBC) concentrates, from an abundant...
Programme: H2020-EU.3.1.
Record Number: 201215
Last updated on: 2017-08-04
New, ex vivo diagnostic system helps predict cancer patient response to treatment
The accurate prediction of patient response is a prerequisite to personalised cancer treatment. Italian SME Cellply has developed the first fully-automated diagnostic system to achieve that, ex vivo, from tumour specimen obtained in a clinical setting.
Programme: H2020-EU.3.1.
Record Number: 202772
Last updated on: 2017-08-21
Available languages: DE, EN, ES, FR, IT, PL
Periodic Reporting for period 1 - ICare (Integrating Technology into Mental Health Care Delivery in Europe)
Mental illness represents an enormous personal, social, and societal burden for European citizens. Existing models of mental health care delivery need to be expanded to reduce this burden. The need to move to novel models to reduce the mismatch between need and provision of...
Programme: H2020-EU.3.1.
Record Number: 201962
Last updated on: 2017-08-04
Periodic Reporting for period 1 - LAB2MARKET (Zebra Academy Ready to Market Feasibility Study)
Stroke is a rapidly developing loss of brain function due to a disturbed cerebral blood supply. Stroke is the second cause of death world-wide and the second cause of disability-adjusted life years in high-income countries. This condition poses a growing global health problem...
Programme: H2020-EU.3.1.
Record Number: 202104
Last updated on: 2017-08-16
Periodic Reporting for period 1 - MIROCALS (Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients)
Amyotrophic Lateral Sclerosis (ALS) is a fatal degenerative disorder of the brain and spinal cord affecting some 40,000 individuals in Europe, causing 11,000 deaths each year. Our pioneering work on riluzole showed that it is possible to modify ALS progression but all...
Programme: H2020-EU.3.1.
Record Number: 202072
Last updated on: 2017-08-17
Periodic Reporting for period 1 - SHIPS (Screening to improve Health In very Preterm infantS in Europe)
The Screening to Improve Health In very Preterm InfantS in Europe (SHIPS) project aims to improve follow-up programmes for children born very preterm in Europe by studying their impact on the children and their families. The project builds on the EPICE - a European cohort of...
Programme: H2020-EU.3.1.2.
Record Number: 201042
Last updated on: 2017-07-28
Periodic Reporting for period 1 - FORECEE (Female cancer prediction using cervical omics to individualise screening and prevention)
The FORECEE project is focused on the shared ambition of a group of leading European clinicians and researchers to promote women’s health and prevent female cancers. The radical progression the consortium wish to see is the implementation of omics based methods into wide...
Programme: H2020-EU.3.1.2.
Record Number: 201993
Last updated on: 2017-08-04
Periodic Reporting for period 1 - MAGIC (Mobile Assistance for Groups  Individuals within the Community - STROKE REHABILITATION)
• What is the problem/issue being addressed?During Phase Zero of the MAGIC-PCP the primary objective was to clarify and agree the ‘problem to be solved’ within the care of people post stroke and the following overarching project requirement was finalised. The key...
Programme: H2020-EU.3.1.
Record Number: 202019
Last updated on: 2017-08-04
Periodic Reporting for period 1 - PHOCNOSIS (Advanced nanophotonic point-of-care analysis device for fast and early diagnosis of cardiovascular diseases)
There is an ever-increasing demand for novel and more efficient point-of-care testing (POCT) devices for the early diagnosis of diseases, with a special interest in cardiovascular diseases (CVD). The most recent statistics from the European Heart Network (EHN) and the European...
Programme: H2020-EU.3.1.
Record Number: 201043
Last updated on: 2017-07-28
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-09-20